HRTX
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Sep 28 closing price
Capitalization
55.85M
42 days until earnings call
Intraday BUY SELL Signals
TENX
Price
$1.85
Change
+$0.04 (+2.21%)
Updated
Sep 28 closing price
Capitalization
67.74M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HRTX vs TENX

HRTX vs TENX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HRTX vs. TENX commentary
Sep 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a StrongBuy and TENX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
HRTX vs TENX: Fundamental Ratings
HRTX
TENX
OUTLOOK RATING
1..100
5693
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8895
P/E GROWTH RATING
1..100
10081
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (38) in the Medical Specialties industry is in the same range as HRTX (51) in the Biotechnology industry. This means that TENX’s stock grew similarly to HRTX’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as HRTX (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to HRTX’s over the last 12 months.

TENX's SMR Rating (98) in the Medical Specialties industry is in the same range as HRTX (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (88) in the Biotechnology industry is in the same range as TENX (95) in the Medical Specialties industry. This means that HRTX’s stock grew similarly to TENX’s over the last 12 months.

TENX's P/E Growth Rating (81) in the Medical Specialties industry is in the same range as HRTX (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXTENX
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
N/A
N/A
COMPARISON
Comparison
Sep 29, 2026
Stock price -- (HRTX: $0.29 vs. TENX: $1.85)
Brand notoriety: HRTX and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 45% vs. TENX: 31%
Market capitalization -- HRTX: $55.85M vs. TENX: $67.74M
HRTX [@Biotechnology] is valued at $55.85M. TENX’s [@Biotechnology] market capitalization is $67.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green while TENX’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 0 green, 5 red.
According to our system of comparison, TENX is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 5 TA indicator(s) are bullish while TENX’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 5 bullish, 2 bearish.
  • TENX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than TENX.

Price Growth

HRTX (@Biotechnology) experienced а +8.07% price change this week, while TENX (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.06%. For the same industry, the average monthly price growth was -11.23%, and the average quarterly price growth was +1.46%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 10, 2026.

TENX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-4.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
HRTX
Daily Signal:
Gain/Loss:
TENX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CLOI52.950.02
+0.04%
VanEck CLO ETF (CLOI)
IQSM38.89N/A
N/A
NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM)
ROAM35.89-0.10
-0.28%
Hartford Multifactor Emerging Markets ETF (ROAM)
JADE79.45-0.88
-1.09%
JPMorgan Active Developing Markets Equity ETF (JADE)
PALD9.40-0.44
-4.51%
Direxion Daily PANW Bear 1X ETF (PALD)

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been closely correlated with SION. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if TENX jumps, then SION could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+2.21%
SION - TENX
92%
Closely correlated
-2.10%
AVXL - TENX
47%
Loosely correlated
-1.26%
HRTX - TENX
41%
Loosely correlated
-0.82%
CORT - TENX
41%
Loosely correlated
-0.40%
MGNX - TENX
32%
Poorly correlated
+8.56%
More